Richmond, VA – According to filings with the U.S. Securities and Exchange Commission, Brainbox Solutions is raising $28,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Donna Edmonds played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Brainbox Solutions
BRAINBox Solutions multi-modality approach is led by the leaders in the industry. It will include blood biomarker panels available on a point of care instrument and standard laboratory systems, as well as neurocognitive testing, to provide objective evidence of injury and prediction of patient recovery. The BRAINBox Solutions multi-modality approach aims to aid clinicians with diagnosis of mTBI and provide information regarding the likelihood of symptoms post injury. Our approach includes blood biomarker panels that are available on both a point of care instrument and standard laboratory systems, as well as neurocognitive testing. Our goal is to provide objective evidence of injury and a prognosis report of a patients likelihood of post-injury symptoms occurrence. Other relevant modalities will continue to be assessed.

To learn more about Brainbox Solutions, visit http://brainboxinc.com/

Contact:
Donna Edmonds, Chief Executive Officer
804-212-2974
dedmonds@brainboxinc.com
https://www.linkedin.com/in/donna-edmonds-4b20aa3a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved